[GRG] Engineering new bone growth MIT


Engineering new bone growth

Coated tissue scaffolds help the body grow new bone to repair
injuries or congenital defects.

Anne Trafton | MIT News Office
August 18, 2014

MIT chemical engineers have devised a new implantable tissue
scaffold coated with bone growth factors that are released slowly
over a few weeks. When applied to bone injuries or defects, this
coated scaffold induces the body to rapidly form new bone that
looks and behaves just like the original tissue.

This type of coated scaffold could offer a dramatic improvement
over the current standard for treating bone injuries, which
involves transplanting bone from another part of the patient’s body
— a painful process that does not always supply enough bone.
Patients with severe bone injuries, such as soldiers wounded in
battle; people who suffer from congenital bone defects, such as
craniomaxillofacial disorders; and patients in need of bone
augmentation prior to insertion of dental implants could benefit
from the new tissue scaffold, the researchers say.

“It’s been a truly challenging medical problem, and we have tried
to provide one way to address that problem,” says Nisarg Shah, a
recent PhD recipient and lead author of the paper, which appears in
the Proceedings of the National Academy of Sciences this week.

Paula Hammond, the David H. Koch Professor in Engineering and a
member of MIT’s Koch Institute for Integrative Cancer Research and
Department of Chemical Engineering, is the paper’s senior author.
Other authors are postdocs M. Nasim Hyder and Mohiuddin Quadir,
graduate student Noémie-Manuelle Dorval Courchesne, Howard
Seeherman of Restituo, Myron Nevins of the Harvard School of Dental
Medicine, and Myron Spector of Brigham and Women’s Hospital.

Stimulating bone growth

Two of the most important bone growth factors are platelet-derived
growth factor (PDGF) and bone morphogenetic protein 2 (BMP-2). As
part of the natural wound-healing cascade, PDGF is one of the first
factors released immediately following a bone injury, such as a
fracture. After PDGF appears, other factors, including BMP-2, help
to create the right environment for bone regeneration by recruiting
cells that can produce bone and forming a supportive structure,
including blood vessels.

Efforts to treat bone injury with these growth factors have been
hindered by the inability to effectively deliver them in a
controlled manner. When very large quantities of growth factors are
delivered too quickly, they are rapidly cleared from the treatment
site — so they have reduced impact on tissue repair, and can also
induce unwanted side effects.

“You want the growth factor to be released very slowly and with
nanogram or microgram quantities, not milligram quantities,”
Hammond says. “You want to recruit these native adult stem cells we
have in our bone marrow to go to the site of injury and then
generate bone around the scaffold, and you want to generate a
vascular system to go with it.”

This process takes time, so ideally the growth factors would be
released slowly over several days or weeks. To achieve this, the
MIT team created a very thin, porous scaffold sheet coated with
layers of PDGF and BMP. Using a technique called layer-by-layer
assembly, they first coated the sheet with about 40 layers of BMP-
2; on top of that are another 40 layers of PDGF. This allowed PDGF
to be released more quickly, along with a more sustained BMP-2
release, mimicking aspects of natural healing.

“This is a major advantage for tissue engineering for bones because
the release of the signaling proteins has to be slow and it has to
be scheduled,” says Nicholas Kotov, a professor of chemical
engineering at the University of Michigan who was not part of the
research team.

The scaffold sheet is about 0.1 millimeter thick; once the growth-
factor coatings are applied, scaffolds can be cut from the sheet on
demand, and in the appropriate size for implantation into a bone
injury or defect.

Effective repair

The researchers tested the scaffold in rats with a skull defect
large enough — 8 millimeters in diameter — that it could not heal
on its own. After the scaffold was implanted, growth factors were
released at different rates. PDGF, released during the first few
days after implantation, helped initiate the wound-healing cascade
and mobilize different precursor cells to the site of the wound.
These cells are responsible for forming new tissue, including blood
vessels, supportive vascular structures, and bone.

BMP, released more slowly, then induced some of these immature
cells to become osteoblasts, which produce bone. When both growth
factors were used together, these cells generated a layer of bone,
as soon as two weeks after surgery, that was indistinguishable from
natural bone in its appearance and mechanical properties, the
researchers say.

“Using this combination allows us to not only have accelerated
proliferation first, but also facilitates laying down some vascular
tissue, which provides a route for both the stem cells and the
precursor osteoblasts and other players to get in and do their
jobs. You end up with a very uniform healed system,” Hammond says.

Another advantage of this approach is that the scaffold is
biodegradable and breaks down inside the body within a few weeks.
The scaffold material, a polymer called PLGA, is widely used in
medical treatment and can be tuned to disintegrate at a specific
rate so the researchers can design it to last only as long as

Hammond’s team has filed a patent based on this work and now aims
to begin testing the system in larger animals in hopes of
eventually moving it into clinical trials.

This study was funded by the National Institutes of Health.

Sent using Hushmail


About Johnny Adams

My full-time commitment is to slow and ultimately reverse age related functional decline to increase healthy years of life. I’ve been active in this area since the 1970s, steadily building skills and accomplishments. I have a good basic understanding of the science of aging, and have many skills that complement those of scientists so they can focus on science to advance our shared mission. Broad experience Top skills: administration, management, information technology (data and programming), communications, writing, marketing, market research and analysis, public speaking, forging ethical win-win outcomes among stakeholders (i.e. high level "selling"). Knowledge in grant writing, fundraising, finance. Like most skilled professionals, I’m best described as a guy who defines an end point, then figures out how to get there. I enjoy the conception, design, execution and successful completion of a grand plan. Executive Director Gerontology Research Group (GRG). Manages Email discussion forum, web site, meetings and oversees supercentenarian (oldest humans, 110+ years) research. CEO / Executive Director Carl I. Bourhenne Medical Research Foundation (Aging Intervention Foundation), an IRS approved 501(c)(3) nonprofit. http://www.AgingIntervention.org Early contributor to Supercentenarian Research Foundation. Co-Founder Geroscience Healthspan Forum. Active contributor to numerous initiatives to increase healthy years of life. Co-authored book on conventional, practical methods available today to slow the processes of aging – nutrition, exercise, behavior modification and motivation, stress reduction, proper supplementation, damage caused by improper programs, risk reduction and others. Fundamental understanding of, and experience in the genomics of longevity (internship analyzing and curating longevity gene papers). Biological and technical includes information technology, software development and computer programming, bioinformatics and protein informatics, online education, training programs, regulatory, clinical trials software, medical devices (CAT scanners and related), hospital electrical equipment testing program. Interpersonal skills – good communication, honest, well liked, works well in teams or alone. Real world experience collaborating in interdisciplinary teams in fast paced organizations. Uses technology to advance our shared mission. Education: MBA 1985 University of Southern California -- Deans List, Albert Quon Community Service Award (for volunteering with the American Longevity Association and helping an elderly lady every other week), George S. May Scholarship, CA State Fellowship. BA psychology, psychobiology emphasis 1983 California State University Fullerton Physiological courses as well as core courses (developmental, abnormal etc). UCLA Psychobiology 1978, one brief but fast moving and fulfilling quarter. Main interest was the electrochemical basis of consciousness. Also seminars at the NeuroPsychiatric Institute. Other: Ongoing conferences, meetings and continuing education. Aging, computer software and information technology. Some molecular biology, biotech, bio and protein informatics, computer aided drug design, clinical medical devices, electronics, HIPAA, fundraising through the Assoc. of Fundraising Professionals. Previous careers include: Marketing Increasing skill set and successes in virtually all phases, with valuable experience in locating people and companies with the greatest need and interest in a product or service, and sitting across the table with decision makers and working out agreements favorable to all. Information Technology: Management, data analysis and programming in commercial and clinical trials systems, and bioinformatics and protein informatics. As IT Director at Newport Beach, CA based technology organization Success Family of Continuing Education Companies, provided online software solutions for insurance and financial professionals in small to Fortune 500 size companies. We were successful with lean team organization (the slower moving competition was unable to create similar software systems). Medical devices: At Omnimedical in Paramount CA developed and managed quality assurance dept. and training depts. for engineers, physicians and technicians. Designed hospital equipment testing program for hospital services division. In my early 20’s I was a musician, and studied psychology and music. Interned with the intention of becoming a music therapist. These experiences helped develop valuable skills used today to advance our shared mission of creating aging solutions.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s